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Role of Extracellular RNA and TLR3-Trif Signaling in Myocardial
Ischemia–Reperfusion Injury
Chan Chen, MD, PhD;* Yan Feng, MD, PhD;* Lin Zou, MD, PhD;* Larry Wang, MD, PhD; Howard H. Chen, PhD; Jia-Yan Cai, BS;
Jun-Mei Xu, MD; David E. Sosnovik, MD; Wei Chao, MD, PhD
Background-—Toll-like receptor 3 (TLR3) was originally identiﬁed as the receptor for viral RNA and represents a major host antiviral
defense mechanism. TLR3 may also recognize extracellular RNA (exRNA) released from injured tissues under certain stress
conditions. However, a role for exRNA and TLR3 in the pathogenesis of myocardial ischemic injury has not been tested. This study
examined the role of exRNA and TLR3 signaling in myocardial infarction (MI), apoptosis, inﬂammation, and cardiac dysfunction
during ischemia-reperfusion (I/R) injury.
Methods and Results-—Wild-type (WT), TLR3/, Trif/, and interferon (IFN) a/b receptor-1 deﬁcient (IFNAR1/) mice were
subjected to 45 minutes of coronary artery occlusion and 24 hours of reperfusion. Compared with WT, TLR3/ or Trif/ mice
had smaller MI and better preserved cardiac function. Surprisingly, unlike TLR(2/4)-MyD88 signaling, lack of TLR3-Trif signaling
had no impact on myocardial cytokines or neutrophil recruitment after I/R, but myocardial apoptosis was signiﬁcantly attenuated
in Trif/ mice. Deletion of the downstream IFNAR1 had no effect on infarct size. Importantly, hypoxia and I/R led to release of
RNA including microRNA from injured cardiomyocytes and ischemic heart, respectively. Necrotic cardiomyocytes induced a robust
and dose-dependent cytokine response in cultured cardiomyocytes, which was markedly reduced by RNase but not DNase, and
partially blocked in TLR3-deﬁcient cardiomyocytes. In vivo, RNase administration reduced serum RNA level, attenuated myocardial
cytokine production, leukocytes inﬁltration and apoptosis, and conferred cardiac protection against I/R injury.
Conclusion-—TLR3-Trif signaling represents an injurious pathway during I/R. Extracellular RNA released during I/R may contribute
to myocardial inﬂammation and infarction. ( J Am Heart Assoc. 2014;3:e000683 doi: 10.1161/JAHA.113.000683)
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H eart diseases including ischemic myocardial infarction(MI) continue to be the leading cause of mortality in the
US.1 While reperfusion therapy such as percutaneous coro-
nary intervention remains the most effective strategy to limit
infarct size and preserve cardiac function, reperfusion itself
can cause injury to myocardium.2 In response to ischemia-
reperfusion (I/R), myocardial tissue exhibits marked innate
immune responses as characterized by cytokine production
and neutrophil inﬁltration2 and cardiomyocyte apoptosis,3 two
major contributors to ischemic myocardial injury and left
ventricular (LV) dysfunction.
Toll-like receptors (TLRs) are a critical component of the
innate immune system and responsible for the host defense
against foreign pathogens via pathogen-associated molecular
pattern (PAMP) recognition.4 Recent studies indicate that
certain TLRs can also function as the sensors for endoge-
nously produced ligands with danger-associated molecular
pattern (DAMP). DAMP ligands are often produced upon
tissue stresses such as ischemia, hypoxia, or trauma.5,6
Examples of DAMP ligands include heat-shock proteins,7 high
mobility group box 1,8 and RNA,9,10 among others. All TLRs,
with the exception of TLR3, signal through myeloid differen-
tiation factor 88 (MyD88)-dependent pathways, whereas TLR3
exclusively and TLR4 partially signal via TIR domain-containing
adaptor inducing IFNb-mediated transcription factor (Trif).
TLR3 was originally identiﬁed as the receptor for double-
stranded RNA of viral origin.11 Stimulation of TLR3-Trif
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signaling activates the transcriptional factors, NF-jB and
interferon regulator factor 3/7 (IRF3/7), and subsequently
results in the production of various cytokines such as type I
IFN, which represents the major host antiviral mechanism.12
Recent studies have suggested that TLR3 signaling may also
recognize endogenous RNA released from necrotic cells in
vitro,10,13,14 mediates RNA-induced apoptosis in pancreatic
b-cells15 and cytokine production in various types of
cultured cells.10,14 In the heart, TLR3-Trif signaling is well
known for its critical role in the host innate immune
response against virus-induced myocarditis. Deﬁciency in
TLR3-Trif signaling leads to an increased viral load, attenu-
ated cytokine production, and increased mortality after viral
infection such as coxsackievirus and encephalomyocarditis
virus.16–18 However, the role of TLR3-Trif signaling in the
pathogenesis of myocardial ischemia-reperfusion injury is
unknown.
In addition to its traditional role as the bridge molecule
between DNA and protein, recent evidence suggest that
extracellular RNA (exRNA) including microRNA (miRNA) and
other non-coding RNA are found in all human body ﬂuid
examined and may play diverse roles such as cellular
differentiation, chromatin modiﬁcation, nuclear factor traf-
ﬁcking, inﬂammation, tissue injury/repair.19–26 ExRNA,
released from necrotic cells, mediates inﬂammatory
responses in a variety of cell cultures including macrophages,
ﬁbroblasts, keratinocytes, and epithelial cells,10,13,14,27 and
may play a role in certain pathological conditions such as
blood coagulation following vascular injury28 and radiation-
induced skin damage.14 Whether or not exRNA plays a role in
myocardial I/R injury is unclear.
Here, we hypothesized that TLR3-Trif signaling represents
an injurious pathway in the heart and contributes to MI during
I/R. We carefully tested the impact of TLR3-Trif deletion on
myocardial cytokine responses, leukocyte inﬁltration, apop-
tosis, MI, and LV dysfunction after I/R. We examined the role
of type I IFN, the downstream effector of TLR3-Trif signaling,
in I/R-induced myocardial injury. We tested the release of
RNA including microRNA from injured cardiomyocytes in vitro
and ischemic myocardial tissue in vivo. Finally, we determined
the role of exRNA in necrotic cell-induced cytokine responses
in cardiomyocyte cultures and in a mouse model of myocar-
dial I/R injury.
Methods
Genetic Mouse Models
C57BL/6J wild-type (WT) and TLR3/ mice were purchased
from the Jackson Laboratory. Trif/ mice were generated by
Yamamoto et al.29 IFNAR1/ mice were kindly provided by
Dr Nir Hacohen at Massachusetts General Hospital (MGH). All
genetically modiﬁed mice were in C57BL/6J background. All
animal care and procedures were performed according to the
protocols approved by the Subcommittee on Research Animal
Care of MGH.
Myocardial Ischemia and Reperfusion Protocol
The surgical procedures of myocardial ischemia/reperfusion
(I/R) injury were performed as previously described.30 Brieﬂy,
male mice were anesthetized by intraperitoneal injection of
ketamine (120 mg/kg) and xylazine (4 mg/kg), intubated,
and ventilated. Body temperature was maintained at 36.5 to
37.5°C. A left intercostal thoracotomy was performed, and
the left anterior descending coronary artery (LAD) was
visualized and ligated with 7-0 silk sutures under a surgical
microscope. For I/R injury, 45 minutes after LAD ligation, the
ligature was released, and reperfusion was visually conﬁrmed.
Sham-operated mice underwent the same procedure without
LAD ligation. The operators were blinded to the study design
and intervention.
Assessment of Myocardial Ischemic Area and
Infarct Size
At the end of reperfusion, LAD was re-ligated. Fluorescent
microspheres were injected into the left ventricle while the
ascending aorta was brieﬂy clamped as previously described.30
The heart was isolated and cut into 5 sections. The areas
devoid of microspheres were determined to be area-at-risk
(AAR). To measure MI size, each section was stained with 1%
triphenyltetrazolium chloride (TTC). Infarct size was calculated
as the ratios of infarcted area (MI/LV,%) over AAR (AAR/LV,%),
ie, MI/AAR9100%.30 Again, the operators were blinded to the
information of study design and intervention.
Echocardiographic Assessment of LV Structure
and Function
Transthoracic echocardiographic (TTE) images were obtained
using a 13.0-MHz linear probe (Vivid 7; GE Medical System)
and interpreted by an echocardiographer blinded to the
experimental design. M-mode images were obtained from a
parasternal short-axis view at the mid-ventricular level with a
clear view of papillary muscle. LV end-diastolic internal
diameter (LVIDd) and LV end-systolic internal diameter
(LVIDs) were measured. Fractional shortening (FS) was
deﬁned as ([LVIDdLVIDs]/LVIDd)9100%. End-diastolic vol-
ume (EDV) and end-systolic volume (ESV) were measured
using area-length method in 2-dimensional parasternal long
axis view. Ejection fraction (EF) was calculated by the formula
([EDVESV]/EDV)9100% as previously described.30,31 The
values of three consecutive cardiac cycles were averaged.
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Myocardial Leukocyte Inﬁltration
Mouse myocardial leukocytes were isolated and quantiﬁed by
ﬂow cytometry following the protocol previously
described.32,33 After removing larger cardiomyocytes through
a ﬁlter, smaller noncardiomyocytes were labeled, at 4°C for
30 minutes, with anti-CD45-PE-Cy5 and anti-Gr-1 mAb for
neutrophil (BD Biosciences), anti-CD3-eFluor450 for T-lym-
phocytes (eBioscience), or anti-F4/80-FITC for macrophages
(eBioscience).
Cytokine Protein Measurement
Luminex multiplex ﬂuorescent bead-based immunoassays
were used to concurrently detect multiple cytokine expression
in myocardial tissues as previously described.32 To measure
MIP-2, ELISA kits were used (R&D).
Quantiﬁcation of Cardiac Tissue and Cell
Cytokine mRNA
qRT-PCR was performed on an Eppendorf PCR system. Data
were normalized by the level of 18s or by GAPDH in each
individual sample. The primer sequences used for qRT-PCR
are listed in Table S1.
C5b-9 Immunohistochemical Staining
C5b-9 deposition was detected immunohistochemically, using
frozen myocardial tissue ﬁxed in Acetone from 8 hearts.
Immunostaining was performed with Leica BOND-MAX TM
(Leica Microsystems Inc). The sections were incubated with
anti-C5b-9 polyclonal rabbit antibody (Abcam: ab55811) at a
dilution of 1:250 in Bond Primary Antibody Diluent
(No. AR9352; Vision BioSystems Inc). Staining for C5b-9
deposition was visualized using Bond Polymer Reﬁne Detec-
tion (No. DS9800; Leica Microsystems Inc). The slides stained
for C5b-9 deposition were counterstained with hematoxylin.
Appropriate positive and negative controls using mouse
kidney were stained along with those slides.
Ex Vivo Annexin V Imaging of Myocardial Cell
Death
Fluorescence reﬂectance imaging (FRI) of myocardial cell
death was performed using a conjugate of annexin V and a
near-infrared ﬂuorochrome (Annexin-Vivo 750=AV-750, Perkin
Elmer). Mice were injected via tail vein with AV-750 at the
onset of reperfusion. Four hours later, mice were euthanized
for AV-750 imaging as we previously described.34 In brief, the
hearts were sectioned and multispectral FRI for AV-750 and
red ﬂuorescent microspheres was performed using the
appropriate ﬁlters on a commercial imagine system (IVIS
Spectrum, Perkin Elmer). This allowed the area of cell death
(AV-750 uptake) to be normalized to the AAR (absence of red
microspheres).
Apoptosis Assays
The apoptosis assays including DNA fragmentation and
caspase-3 activity were measured as described previ-
ously.34,35
Cardiomyocyte Isolation and Cultures
Rat and mouse neonatal cardiomyocytes were isolated and
cultured as previously described with modiﬁcations.34,36
NF-jB Activation
NF-jB activation was measured using a p65 Transcription
Factor Kit (Thermo Scientiﬁc). A 96-well plate coated with a
DNA binding sequence speciﬁc for active form of NF-jB. In
brief, 20 mg heart tissue samples were lysed in 100 lL of
M-PER lysis buffer and 25 lL of supernatant of lysate were
loaded into the plate. After incubation and washing, the plate
was incubated with antibody to p65, and then developed for
luminescence.
Necrotic Cell Treatment
Necrotic raw macrophages (M/) or cardiomyocytes in serum-
free DMEM medium containing 0.05% BSA in 12-well plates
were generated by freeze and thaw (3 cycles of 10 minutes
freeze at 80°C followed by 10 minutes thaw at 37°C).
Necrotic cell suspensions were stored at 80°C for later use.
To test the effect of necrotic cells, rat or mouse neonatal
cardiomyocytes were cultured in 12-well plates (for cellular
cytokine RNA) or 96-well plate (for medium MIP-2 ELISA). The
necrotic Raw M/ or cardiomyocytes were incubated with
cultured cardiomyocytes at the speciﬁc ratios (see ﬁgure
legends for details) at 37°C for 8 hours in the presence or
absence of RNase (2.8 U/mL) or DNase (2.8 U/mL). Cellular
cytokine mRNA or medium cytokine protein was analyzed with
qRT-PCR or ELISA, respectively.
In Vivo RNase Administration and Serum
Preparation
Bovine pancreatic RNase A (Invitrogen) was ﬁltered through
30 kDa cut-off ﬁlter and stored at 4°C. As illustrated in Figure
9A, normal saline (N.S.) or 3 doses of RNase A were
administered as follows: 500 lg/100 lL, sc, 30 minutes
prior to, 200 lg/200 lL, ip, right before, and 500 lg/
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100 lL, sc, 2 hours after coronary occlusion. In the exper-
iments designed to test serum RNase activity (Figure 9B), no
surgical procedure was performed. Mouse blood was col-
lected at 1 hour, 4 hours, and 24 hours after the second dose
of RNase injection. To test serum RNase activity, serum was
ﬁltered through a 30-kDa cut-off ﬁlter to remove most serum
proteins from RNase (17 kDa).
MicroRNA Quantiﬁcation
Total RNA was isolated from culture medium or serum using
Trizol LS. Caenorhabditis elegans (C. elegans) microRNA
(miRNA)-39 was added as the miRNeasy Serum/Plasma
Spike-in Control. Reverse transcription was performed accord-
ing to the miScript II RT kit. MicroRNA was quantiﬁed using
miScript SYBR Green PCR kit following the manufacturer
protocol (Qiagen). Relative miRNA expression was calculated
using the comparative Ct method (2ΔΔCt).
Statistical Analysis
Statistical analysis was performed using Graphpad Prism 5
software. Unless stated otherwise, all data were expressed as
meansSE. For comparisons between groups (eg, sham
versus I/R or 2 I/R groups), 2-tailed, unpaired Student t test
was used for analysis of MI sizes, in vivo annexin V imaging,
leukocyte inﬁltrations, and miRNA levels. To assess cardiac
function changes over time (between the baseline and 24 h
post-I/R) within a given group (eg, WT or KO), paired t test
was used. Two-way ANOVA with Bonferroni post hoc test was
used for the other experiments. The null hypothesis was
rejected for P<0.05.
Results
Genetic Deletion of TLR3 Reduces Myocardial
Infarction and Improves Function after I/R
Compared with wild-type (WT) mice, mice deﬁcient of TLR3
(TLR3/) had signiﬁcantly smaller MI (28% reduction) as
measured by TTC staining (MI/AAR=315% versus 433%,
P<0.05) following 45 minutes of coronary artery occlusion
and 24 hours of reperfusion (Figure 1). Transthoracic echo-
cardiography (TTE) studies indicated that left ventricle (LV)
contractile function was similar between WT and TLR3/
mice at the baseline (Figure 1, Table 1). Twenty-four hours
after I/R, FS and EF in WT mice were decreased by 52% and
39% from the baseline, respectively (P<0.001). Consequently,
LVIDd and LVIDs were increased by 15% and 87%, respec-
tively (P<0.001). In comparison, TLR3/ mice had signiﬁ-
cantly improved LV contractile function as demonstrated by
better FS (+41%) and EF (+24%), and smaller LVIDs (21%)
(P<0.01) (Table 1).
TLR3 Deﬁciency Has No Impact on Myocardial
Inﬂammation after I/R
TLR3 is known to regulate cellular inﬂammation via NF-jB and
IRF3/7-type I interferon (IFN)11 and plays a critical role in viral
myocardial inﬂammation.16,17 We tested whether or not TLR3
Figure 1. TLR3/ mice have smaller MI and better-preserved cardiac function after I/R. A, Representative MI and AAR images of heart
sections from WT and TLR3/ mice after I/R (45 min/24 h). Infarcted myocardium is shown white, whereas AAR is the area devoid of red
ﬂuorescent light. B, Cumulative data of AAR and MI. C, Representative M-mode echocardiograms are from WT and TLR3/ mice before
(Baseline) and 24 hours after reperfusion (I/R). *P<0.05. AAR indicates area-at-risk; I/R, ischemia/reperfusion; LV, left ventricle; MI, myocardial
infarction; TLR3, toll-like receptor 3; WT, wild type.
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deﬁciency impacts on myocardial inﬂammation after I/R. To
ensure the speciﬁc defect of TLR3 signaling in TLR3/ mice,
we treated isolated macrophages with TLR3 ligand. Poly I:C led
to marked cytokine and type I/II IFN mRNA production in WT
cells, but failed to do so in TLR3/ cells (Figure S1). As shown
in Figure 2A, WT and TLR3/ mice had a basal level of
cardiac cytokine protein expression and to our surprise, both
had very similar, cytokine responses 24 hours after I/R,
including IL-6, MCP-1, and CXCL1. Within the same time
frame, WT and TLR3/mice had a signiﬁcant increase only in
IFNb mRNA (Figure 2B). Moreover, while I/R induced a
marked myocardial neutrophil inﬂux in WT mice, there was
no statistically signiﬁcant difference between WT and TLR3/
mice (9.09104 versus 12.49104) (Figure 2C). Similarly, I/R
induced marked C5b-9 deposition in the ischemic myocardium
and there was no apparent difference between WT and TLR3/
mice (Figure 3). These data suggest that the myocardial innate
immune responses tested during I/R do not involve TLR3
signaling.
Absence of Trif Signaling Reduces MI Sizes and
Preserves LV Function
Trif is the adaptor molecule that is pivotal for both TLR3 and
TLR4 signaling.29,37 We tested if signaling via Trif was
essential for I/R-induced MI. Figure 4A shows the represen-
tative photographs of MI and AAR of both WT and Trif/
mice after I/R. The accumulated data in Figure 4B indicates
that I/R resulted in 413% of MI (MI/AAR) in WT mice and
143% in Trif/ mice, a 67% of reduction in MI size
(P<0.001). TTE studies indicated that cardiac contractile
function was similar between the 2 strains of mice at the
baseline (Figure 4C, Table 2). Twenty-four hours after I/R, FS
and EF in WT mice were decreased compared with the
baseline (P<0.001), and both LVIDd and LVIDs were signif-
icantly increased. Consistent with the MI data, Trif/ mice
had markedly improved LV contractile function as demon-
strated by better FS (+44%) and EF (+39%) and smaller LVIDs
(25%) (P<0.01) when compared with WT mice following I/R
(Table 2).
Lack of Trif leads to Attenuated Myocardial
Apoptosis in Ischemic Heart
Previous studies have shown that Trif signaling can effectively
induce apoptosis when over expressed, suggesting a possible
link between Trif signaling and apoptosis pathway.38 To
determine the underlying mechanism for the reduced myo-
cardial injury in Trif/ mice, we investigated the impact of
Trif on myocardial apoptosis induced by I/R. WT and Trif/
mice were subjected to 45 minutes of coronary occlusion and
4 hours of reperfusion. Myocardial apoptosis was assessed
by ex vivo ﬂuorescence reﬂectance imaging (FRI) of a near-
infrared Annexin V conjugate (AV-750), DNA laddering, and
caspase-3 activity. As illustrated in Figure 5, 4 hours of
reperfusion resulted in signiﬁcant MI and marked accumula-
tion of ﬂuorescent AV-750 in the myocardium (Figure 5A
through 5C). Importantly, Trif/ mice had smaller infarct
sizes and reduced AV-750 accumulation compared with that
of WT mice. Genomic DNA extracted from the ischemic
myocardium of WT mice exhibited characteristic DNA ladder-
ing after I/R, whereas there was a marked decrease in DNA
laddering in Trif/ mice (Figure 5D). Finally, WT mice
exhibited an increase in myocardial caspase-3 activity after
I/R, whereas Trif/ mice showed an attenuated level of
caspase-3 activity (Figure 5E). Taken together, these data
suggest that Trif signaling likely mediates an apoptosis
pathway during cardiac I/R.
Table 1. Serial Echocardiographic Measurements Before and After I/R in WT and TLR3/ Mice
Baseline 24 Hours Post I/R Changes Over Time (%)
WT TLR3/ WT TLR3/ WT TLR3/
HR, bpm 7096 67310 64017‡‡ 63716 10 5
LVIDd, mm 3.30.1 3.30.1 3.80.1‡‡ 3.50.1 15 6
LVIDs, mm 1.50.0 1.50.0 2.80.2‡‡‡ 2.20.2**†† 87 47
FS, % 561 541 272‡‡‡ 383**††† 52 30
EF, % 751 772 463‡‡‡ 575*††† 39 26
n 8 9 8 9
Values are presented as meanSE. Paired t tests were used for comparison within the groups (WT or TLR3/) and unpaired t tests for comparisons between the groups (WT vs TLR3/).
EF indicates ejection fraction; FS, fractional shortening; HR, heart rate; I/R, ischemia/reperfusion; LVIDd, LV internal diameter at the end of diastole; LVIDs, LV internal diameter at the end
of systole; TLR3, toll-like receptor 3; WT, wild type.
*P<0.05, **P<0.01 vs WT-I/R.
††P<0.01, †††P<0.001 vs TLR3/-baseline.
‡‡P<0.01, ‡‡‡P<0.001 vs WT-Baseline.
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Trif Signaling Has No Effect on Myocardial
Inﬂammation During I/R
We conﬁrmed that Trif deﬁciency speciﬁcally blocked TLR3-
mediated cytokine response as described in Figure S2. In vivo,
24 hours of reperfusion induced a signiﬁcant increase in
myocardial IL-6, MCP-1, CXCL1 expression (Figure 6A),
whereas 4 hours of reperfusion induced a signiﬁcant increase
in both type I/II IFN mRNA production (Figure 6B). To our
surprise, absence of Trif had no effect on the level of
myocardial cytokine expression (Figure 6A and 6B). Moreover,
there was no difference between WT and Trif/ in the total
numbers of CD45+ and Gr-1+ neutrophils recruitment
(14.59104 versus 13.39104) after I/R. In contrast, MyD88
deﬁciency resulted in a marked reduction in neutrophil
inﬁltration (Figure 6C). These data suggest that TLR3-Trif
Figure 2. Loss of TLR3 has no impact on myocardial inﬂammation during I/R. WT and TLR3/ mice were subjected to sham operation or
coronary artery ligation for 45 minutes and then 24 hours of reperfusion. A, Cytokine proteins. At the end of reperfusion, myocardial cytokine
protein production was measured by Luminex assays. B, Cytokine mRNA. C, Myocardial neutrophil inﬁltration after I/R. After enzymatic digestion,
cardiomyocytes were removed and remaining cardiac cells were gated on CD45 and Gr-1 and analyzed with ﬂow cytometry. Left, total CD45+/Gr-
1+ cells/heart in WT and TLR3/ mice subjected to sham and I/R. n=3 mice/group. Right, representative examples of FACS plots of myocardial
cells from WT-I/R and TLR3/-I/R mice. FSC, forward scatter; SSC, side scatter. **P<0.01, ***P<0.001. CXCL1 indicates chemokine (C-X-C
mortif) ligand 1; FACS, ﬂuorescence-activated cell sorting; I/R, ischemia/reperfusion; IFN, interferon; IL, interleukin; MCP-1, monocyte
chemotactic protein-1; TLR3, toll-like receptor 3; WT, wild type.
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signaling plays no major contributory role in myocardial
cytokine response and neutrophil recruitment following I/R.
Absence of Type I IFN Receptor Does Not Change
MI Size Following I/R
One of the key downstream effectors of TLR3-Trif signaling is
Type I IFN,39,40 which is critical for mediating myocardial
inﬂammation during the early phase of viral infection.18 We
wondered if Type I IFN would mediate myocardial injury after
I/R. IFNAR, including the subunits IFNAR1 and IFNAR2, are
the binding sites of type I IFNs.41 Mice lacking IFNAR are
completely unresponsive to type I IFN.42 We subjected
IFNAR1/ mice to the same I/R protocol as that of WT
and Trif/ mice and found no difference in MI sizes (Figure
S3) or LV function (data not shown) between IFNAR1/ and
WT mice. These data suggest that type I IFN is not responsible
for I/R-induced myocardial injury.
RNA Is Released from Injured Macrophages and
Cardiomyocytes
We stained intracellular RNA with SYTO-RNASelect Stain
(SYTO), a cell-permeable and highly RNA-selective ﬂuorescent
Figure 3. C5b-9 myocardial deposition following I/R. WT or TLR3/ mice were subjected to either Sham or I/R. RNase was administered to
WT mice according to a protocol described in the Methods. Twenty-four hours after LAD ligation, mice were euthanized, the heart sectioned and
stained for C5b-9 as described in the Methods. I/R indicates ischemia/reperfusion; LAD, left anterior descending coronary artery; TLR3, toll-like
receptor 3; WT, wild type.
Figure 4. Trif/ mice have reduced MI and better-preserved cardiac function after I/R. A, Representative MI and AAR images of heart sections
from WT and TLR3/ mice after I/R. Infarcted myocardium is shown white, whereas AAR is the area devoid of red ﬂuorescent light. B,
Cumulative data of MI and AAR. C, Representative M-mode echocardiograms of WT and Trif/ mice before (baseline) and 24 hours after I/R.
***P<0.001. AAR indicates area-at-risk; I/R, ischemia/reperfusion; LV, left ventricle; MI, myocardial infarction; TLR3, toll-like receptor 3; Trif, TIR
domain-containing adaptor inducing IFNb—mediated transcription factor; WT, wild type.
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dye.43 SYTO-stained RNA was located primarily in the nucleus
(Figure 7A). To detect exRNA, cells were treated without or
with 2 injurious conditions including freeze and thaw or
hypoxia/serum deprivation (Figure 7B). In untreated cells
(None), RNA was located in cells and mainly in 3 sizes, 28S,
18S, and small molecular weights. However, in necrotic cell
cultures, both macrophages (M/) and isolated rat cardiomyo-
cytes (CM), exRNA was detected in the culture media as
stained by SYTO (Figure 7B). RNase, but not DNase, com-
pletely digested the SYTO-stained exRNA in vitro (Figure 7B).
Moreover, qRT-PCR demonstrated that injured cardiomyo-
cytes released miRNA into the media including miR-208a
(2285-fold), miR499 (752-fold), miR-1 (147-fold), and miR-133
(45-fold) after hypoxia/serum deprivation (Figure 7C).
Necrotic M/ and Cardiomyocytes Induce
Cytokine Response in Cardiomyocytes—Role of
RNA and TLR3
When treated with necrotic M/, rat cardiomyocytes produced
multiple cytokine mRNA including IL-1b (12.1-fold), MIP-2
(16.4-fold), IL-6 (11.8-fold), CXCL1 (5.5-fold), and MCP-1
(14.7-fold) (Figure 8A). When necrotic cells were pretreated
with RNase, cytokine mRNA responses were either abolished
(IL-1b) or signiﬁcantly inhibited (MIP-2, IL-6, CXCL1). In
contrast, the same concentration of DNase had no effect on
the cytokine production. We also tested MIP-2 protein
production in cardiomyocytes in response to necrotic M/
and cardiomyocytes (Figure 8B). Rat cardiomyocyte cultures
were treated with 2 concentrations of necrotic M/ or
cardiomyocytes in the presence or absence of RNase or
DNase. Both necrotic M/ and rat cardiomyocytes induced a
dose-dependent increase in MIP-2 protein production. Again,
RNase but not DNase attenuated the cytokine response.
Necrotic cardiomyocytes also induced an equally robust MIP-
2 response in cardiac ﬁbroblasts (data not shown). Moreover,
to determine if necrotic cell-induced cytokine response was
mediated by TLR3, we tested the effect of necrotic cardio-
myocytes in WT and TLR3/ mouse cardiomyocytes. Similar
to rat cardiomyocytes, WT mouse cardiomyocytes produced
MIP-2 in response to necrotic rat cardiomyocytes in a dose-
dependent manner. TLR3/ cardiomyocytes also responded
to the necrotic cells but at much attenuated levels as
compared with WT cardiomyocytes (Figure 8C). Of note, these
cultured TLR3/ cardiomyocytes responded normally to
LPS, a TLR4 ligand, as did WT cells, but failed to respond to
poly I:C. Taken together, these data clearly demonstrate that
cellular RNA is released from cardiomyocytes upon injury and
that necrotic cells, both macrophages and cardiomyocytes,
are capable of inducing robust cytokine responses in cardio-
myocytes through RNA- and TLR3-dependent mechanisms.
Role of exRNA in Myocardial Inﬂammation and
Injury Following I/R
Similar to cultured cardiomyocytes subjected to hypoxia/
serum deprivation in vitro (Figure 7B and 7C), transient
myocardial ischemia in vivo (45 minutes of ischemia and
3 hours of reperfusion) induced a marked increase in
circulating plasma RNA including miR-208a (4.0-fold), miR-
499 (8.6-fold), miR-1 (6.4-fold), and miR-133 (4.9-fold),
presumably released from the ischemic myocardium
(Figure 7D). To explore the role of exRNA in ischemic
myocardial injury, we administered RNase to animals as
described previously.28 The in vivo RNase administration
protocol (Figure 9A) led to an increased serum RNase activity
for up to at least 4 hours as evidenced by an enhanced RNA
degradation in vitro (Figure 9B) and signiﬁcant reduction in
Table 2. Serial Echocardiographic Measurements Before and 24 Hours After I/R in WT and Trif/ Mice
Baseline 24 Hours Post I/R Changes Over Time (%)
WT Trif/ WT Trif/ WT Trif/
HR, bpm 6996 70019 69717 65421 0 7
LVIDd, mm 3.20.1 3.20.0 3.60.1‡ 3.40.1 13 6
LVIDs, mm 1.40.0 1.50.1 2.40.2‡‡ 1.80.2** 71 20
FS, % 571 552 324‡‡‡ 464**† 44 16
EF, % 812 812 496‡‡ 687* 40 16
n 6 5 6 5
Values are presented as meanSE. Paired t tests were used for comparison within the groups (WT or TLR3/) and unpaired t tests for comparisons between the groups (WT vs TLR3/).
EF indicates ejection fraction; FS, fractional shortening; HR, heart rate; I/R, ischemia/reperfusion; LVIDd, LV internal diameter at the end of diastole; LVIDs, LV internal diameter at the end
of systole; Trif, TIR domain-containing adaptor inducing IFNb—mediated transcription factor; WT, wild type.
*P<0.05, **P<0.01 vs WT-I/R.
†P<0.05 vs Trif/-baseline.
‡P<0.05, ‡‡P<0.01, ‡‡‡P<0.001 vs WT-baseline.
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the circulating endogenous miRNA (miR-1 and miR-133) in
both Sham and I/R mice (Figure 9C). Moreover, compared
with mice administered with normal saline, mice treated with
3 doses of RNase as detailed in Figure 9A had signiﬁcantly
reduced myocardial cytokine responses including CXCL1,
IL-1b, IL-6, MIP-2, and TNFa (Figure 10A), attenuated
Figure 5. Trif/ mice have attenuated myocardial apoptosis and decreased caspase-3 activity. A, Representative images of TTC stained
myocardium section (left) and the corresponding ﬂuorescence reﬂectance images of ﬂuorescent annexin V construct, AV-750, injected at the
onset of reperfusion (right), were acquired at 4 hours of reperfusion from WT and Trif / mice. B, The area of annexin positivity, expressed as the
percentage of pixels in the AAR with an AV-750 signal >2 SD above background, is signiﬁcantly reduced in the Trif/ mice. C, Cumulative data of
AAR and MI. D, Myocardial DNA fragmentation. Genomic DNA was isolated 4 hours after reperfusion and subjected to agarose gel
electrophoresis. E, Myocardial caspase-3 activity was assayed after I/R (45 min/4 h). Sham, n=8 mice/group; I/R, n=10 mice/group. *P<0.05,
**P<0.01. AAR indicates area-at-risk; AV-750, Annexin-Vivo 750; I/R, ischemia/reperfusion; LV, left ventricle; MI, myocardial infarction; Trif, TIR
domain-containing adaptor inducing IFNb—mediated transcription factor; TTC, triphenyltetrazolium chloride; WT, wild type.
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myocardial CD45+/Gr-1+ neutrophil and CD3+ T lymphocyte
inﬁltration (Figure 10B), a tendency of reduced NF-jB activity
(Figure 10C), and decreased myocardial caspase-3 activity
(Figure 10D) after I/R. However, while I/R induced marked
C5b-9 deposition in the ischemic myocardium, RNase treat-
ment had no apparent effect on the complement deposition
(Figure 3). Finally, RNase-treated mice had modest but signif-
icantly smaller MI compared with the saline-treated control
mice (MI/AAR: 233% vs 332%, 30% reduction, P<0.01) at
24 hours after I/R (Figures 10E and 10F). Taken together,
Figure 6. Lack of Trif has no impact on myocardial inﬂammation after I/R. Mice were subjected to I/R (45 min/4 h or 24 h). A, Myocardial
cytokine protein expression. Twenty-four hours after reperfusion, cytokine proteins were measured using Luminex. B, Myocardial cytokine mRNA.
Four hours after reperfusion, IFN mRNAs were assayed using qRT-PCR. C, Myocardial neutrophil inﬁltration after I/R. Left, total CD45+/Gr-1+ cells
in the hearts of WT, Trif/, or MyD88/ mice that were subjected to sham or I/R. n=3 mice/group. Right, representative examples of FACS
plots of myocardial cells from mice subjected to I/R. FSC, forward scatter; SSC, side scatter. *P<0.05, **P<0.01, ***P<0.001. CXCL1,
chemokine (C-X-C mortif) ligand 1; I/R, ischemia/reperfusion; IFN, interferon; IL, interleukin; MCP-1, monocyte chemotactic protein-1; MyD88,
myeloid differentiation factor 88; qRT-PCR, quantitative real time polymerase chain reaction; Trif, TIR domain-containing adaptor inducing IFNb—
mediated transcription factor; WT, wild type.
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these data suggest that RNA is released from ischemic
myocardium following I/R and exRNA may play a role in
mediating myocardial inﬂammation, apoptosis, and infarction.
Discussion
We have made 4 major observations in this study. First, we
show that genetic deletion of TLR3 or Trif confers a signiﬁcant
protection against ischemic myocardial injury with reduced
infarct size and improved LV function. Second, we demon-
strate that signaling via Trif mediates myocardial apoptosis
during I/R as evidenced by reduced cardiac AV-750 ﬂuores-
cent signals in ischemic myocardium, reduced DNA laddering,
and attenuated caspase-3 activation in Trif/ animals.
Unlike its critical role in myocardial innate immune response
against viral myocarditis and distinctly different from TLR2/
Figure 7. RNAs are released from injured cells in vitro and ischemic myocardium in vivo. A, Representative pictures of SYTO-stained
intracellular RNA in macrophages (M/) and in rat cardiomyocytes (CM). SYTO RNA-select green ﬂuorescent dye was used to stain intracellular
RNA. CM were also co-stained for troponin T shown in red. B, SYTO ﬂuorescent imaging of RNA gel electrophoresis. M/ and CM were subjected
various injurious conditions as follows: Freeze/thaw (F/T), 3 cycles910 minutes at 80°C followed by 10 minutes93 at 37°C; H/SD, hypoxia in
serum/glucose-free medium for 24 hours. Cells and media were harvested separately and extracted for RNA with Trizol and Trizol LS,
respectively. Puriﬁed RNA was stained with SYTO ﬂuorescence dye followed by gel electrophoresis. In separate experiments, the same amount of
puriﬁed RNA was incubated without or with RNase or DNase before SYTO staining and gel electrophoresis. C, miRNA is released from hypoxic rat
CM in vitro. Cultured CM were subjected to hypoxia/SD for 24 h, whereas control CM (None) were brieﬂy treated with serum-free RPMI-1640
medium for 5 minutes. n=3/group. D, Circulating miRNA after sham or myocardial I/R (45 min/3 h) n=3 mice/group. To measure miRNA,
culture media or sera were extracted for total RNA using Trizol LS. miRNA were measured by qRT-PCR using miScript II RT and miScript SYBR
Green PCR kits. Cel-miR-39 was used as the spike-in control. *P<0.05, **P<0.01. I/R indicates ischemia/reperfusion; miRNA, microRNA;
qRT-PCR, quantitative real time polymerase chain reaction.
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Figure 8. Necrotic M/ and cardiomyocytes induce robust cytokine production. A, Necrotic mouse macrophages (mM/) induce cytokine mRNA
production in rat cardiomyocytes (rCM). Cultured rCM (0.89106 cells/well in 12-well plate) were incubated with necrotic (N.C.) mM/ (N.C./
culture cells ratio=4/1) in the absence or presence of 2.8 U/mL of RNase or DNase as indicated for 8 hours. PolyI:C (I:C) is a TLR3 ligand. B,
Necrotic cells induce MIP-2 protein production in rCM. Necrotic mM/ or rCM preparations were added to rCM cultures (0.89105 cells/well in 96-
well plate) in the presence or absence of RNase or DNase for 8 hours. Medium MIP-2 was assayed. The ratios represent N.C./culture cells. C,
MIP-2 production in culture media of WT and TLR3/ mouse CM (mCM). Necrotic CM were incubated with WT or TLR3/ mCM (1.19105 cells/
well in 96-well plate) for 8 hours. Medium MIP-2 was assayed. I:C, poly I:C, 20 lg/mL; LPS, lipopolysaccharide, 10 ng/mL. Each data point in A
through C represents meanSE of triplicate measurements and each experiment was repeated 3 times. *P<0.05, **P<0.01, ***P<0.001. CXCL1
indicates chemokine (C-X-C mortif) ligand 1; I/R, ischemia/reperfusion; IFN, interferon; IL, interleukin; MCP-1, monocyte chemotactic protein-1;
MIP-2, macrophage inﬂammatory protein-2; TLR3, toll-like receptor 3; WT, wild type.
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4-MyD88 signaling,30,32,44,45 TLR3-Trif signaling exhibits
minimal impact on myocardial cytokine response including
its downstream effector type I IFN and on myocardial
neutrophil inﬁltration during I/R. Third, we show that cellular
RNA is released from injured cardiomyocytes in vitro and from
ischemic myocardium in vivo and that necrotic cells induce
robust cytokine responses in cardiomyocytes, which is
markedly reduced by RNase and signiﬁcantly blocked in
TLR3/ cardiomyocytes. Finally, in vivo RNase administra-
tion reduces serum RNA level, attenuates myocardial cytokine
production and leukocytes inﬁltration, and confers signiﬁcant
cardiac protection against I/R injury.
Previous studies show that genetic deletion or pharmaco-
logical inhibition of TLR2/4 or their adaptor molecular MyD88
leads to reduced myocardial cytokine production, attenuated
neutrophil recruitment, decreased C3 deposition, and reduced
MI.30,32,34,44–46 TLR2/4-MyD88 signaling may contribute to
I/R-induced myocardial injury by mediating a pro-inﬂammatory
response in ischemic heart.6 In addition to controlling the
myocardial environment such as local cytokine production,
TLR2/4-MyD88 signaling may also modulate the functions of
circulating neutrophils.30,32,44,47 In an in vivo model of
neutrophil migration and a chimeric model of MyD88 deletion,
we have shown that MyD88 signaling is essential for
maintaining neutrophil migratory function and the chemokine
receptor CXCR2 expression and that MyD88 signaling in
circulating neutrophils plays a critical role in I/R-induced
myocardial injury.32 Similarly, the current study demonstrates
Figure 9. In vivo administration of RNase A increased serum RNase activity. A, Experimental protocol of RNase injection, LAD ligation, and
blood sampling. Three doses of RNase A (or normal saline, N.S., not shown) were administered as follows: 500 lg/100 lL, sc, 30 minutes prior
to, 200 lg/200 lL, ip, right before, and 500 lg/100 lL, sc, 2 hours after LAD ligation. B, RNA digestion by serum RNase. No surgical procedure
was performed in this set of experiments. Mouse blood was collected at 1 hour, 4 hours, and 24 hours after the second dose of N.S. or RNase as
indicated above and serum was prepared. Serum was ﬁltered through a 30-kDa cut-off ﬁlter to remove most of serum proteins. Filtered serum
was incubated with 1.5 lg of puriﬁed Raw M/ RNA at 37°C for 2 hours followed by SYTO staining and RNA gel electrophoresis. Lane 1:
Untreated RNA, Lane 2-5: RNA treated with serum from saline-treated mice; Lane 6-11: RNA treated with serum from RNase-treated mice. C,
Effect of RNase A on serum endogenous miRNA. Mice treated with N.S. or RNase as noted above were subjected to sham or I/R. Three hours
after reperfusion, serum was collected and analyzed for miRNA. Sham, n=3; I/R, n=7. I/R indicates ischemia/reperfusion; LAD, left anterior
descending coronary artery; miRNA, microRNA.
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that absence of TLR3-Trif signaling leads to reduced myocar-
dial injury and improved LV function. It is noteworthy,
however, that Trif/ mice had much more dramatic reduc-
tion in MI size than TLR3/ mice when compared with WT
(68% versus 28% reduction in MI size). We speculate this
might be due to the fact that Trif transduces the signaling
from both TLR3 and TLR4. Deletion in Trif would result in
blockage of TLR3 and a part of TLR4 signaling. In stark
contrast to TLR2/4-MyD88 signaling, TLR3-Trif signaling
appears to mediate I/R injury via a mechanism independent
of inﬂammation since the absence of TLR3-Trif has no impact
on cardiac cytokine production or on neutrophil recruitment in
response to I/R. Thus, these data suggest that despite its
ability to mediate inﬂammatory cytokine response in immune
cells and during viral myocarditis and bacterial sepsis,10,16–18
TLR3-Trif signaling may make no major contribution to
myocardial inﬂammation in response to I/R.
Type I IFN is the key downstream effector of TLR3-Trif
signaling and plays a pivotal role in host antiviral defense.18
Similar to viral myocarditis, I/R induces signiﬁcant myocardial
type I/II IFN response. However, absence of TLR3 or Trif
did not affect the myocardial IFN response, suggesting that
Figure 10. Effect of RNase administration on myocardial inﬂammation, apoptosis, and infarct sizes after I/R. A, Effect of RNase on myocardial
cytokine mRNA. Mice were treated with N.S. or RNase and subjected to sham or I/R. Three hours after reperfusion, myocardial cytokines were
analyzed by qRT-PCR. Sham, n=3; I/R, n=5. B, Effect of RNase treatment on myocardial inﬁltration of CD45+1/Gr-1+ neutrophil, CD3+ T
lymphocyte and F4/80+ macrophage after I/R. A representative FACS plot of neutrophils is shown. C, Effect of RNase on myocardial NF-jB
activity. IR. Sham, n=3; I/R, n=5. D, Effect of RNase on myocardial caspase-3 activity after 4 hours of reperfusion. Sham, n=3; I/R, n=5. E, Effect
of RNase on MI after I/R. n=19/group. F, Representative of TTC staining (left) and ﬂuorescent microsphere distribution (right) of myocardial
sections from N.S.- or RNase-treated mice. AAR is indicated by the areas devoid of red ﬂuorescent light and the infarct area shown as white.
*P<0.05, **P<0.01, ***P<0.001. AAR indicates area-at-risk; CXCL1, chemokine (C-X-C mortif) ligand 1; I/R, ischemia/reperfusion; IFN,
interferon; IL, interleukin; LV, left ventricular; MI, myocardial infarction; MCP-1, monocyte chemotactic protein-1; MIP-2, macrophage
inﬂammatory protein-2; NF-kB, nuclear factor-kappaB; N.S., normal saline; qRT-PCR, quantitative real time polymerase chain reaction; RLU,
relative luminescence units; TNF, tumor necrosis factor; TTC, triphenyltetrazolium chloride.
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I/R-induced IFN expression in the heart is probably not
mediated by TLR3-Trif signaling. The fact that IFNAR/ mice
have the similar infarct size as WT mice demonstrates that type
I IFN plays no major role in I/R-induced myocardial injury.
In the current study, we took 3 different approaches to
detect myocardial apoptosis: ex vivo cardiac AV-750 FRI, DNA
laddering, and caspase-3 activity. The ﬂuorescent AV-750
construct has been used by our lab in a mouse model of I/R
injury34 and 99Tc-labeled annexin-V used in patients to image
myocardial injury.48 We found that Trif deﬁciency led to
signiﬁcant attenuation of myocardial apoptosis after I/R
injury. This is consistent with a previous in vitro study that
demonstrates that Trif induces cellular apoptosis through a
RIP/FADD/caspase-8-dependent pathway.49 Thus, the cur-
rent study establishes Trif signaling as a pathway in the heart
that controls myocardial apoptosis and mediates myocardial
injury during I/R.
To determine the role of exRNA in cardiomyocyte cytokine
response and in ischemic myocardial injury, we ﬁrst showed
that under stressful conditions such as hypoxia/serum
deprivation and myocardial I/R, cardiomyocytes and the
heart, respectively, released substantial amount of RNA.
Using a sensitive qRT-PCR, we detected the release of
several miRNA (miR-208a, miR-499, miR-1, and miR-133)
that are reportedly highly present in cardiomyocytes and in
skeletal muscle cells with miR-208 expressed exclusively in
the heart.50,51 The signiﬁcance of these miRNA in ischemic
myocardial injury is evidenced by the fact that the circulating
levels of these miRNA are dramatically elevated after acute
MI compared with control subjects in patients as well as
experimental models.52,53 We also demonstrated that iso-
lated cardiomyocytes responded to necrotic macrophages
and cardiomyocytes and produced multiple cytokines such as
IL-1b, MIP-2, IL-6, CXCL1, and MCP-1. The necrotic cell-
induced cytokine response is dose-dependent and signiﬁ-
cantly attenuated by RNase treatment of the necrotic cells,
but not by DNase. These data suggest that similar to what
has been reported in a variety of cell types, RNA associated
with damaged cells is capable of inducing cytokine
responses in cardiomyocytes. Furthermore, we demonstrated
that necrotic cell-induced MIP-2 production was signiﬁcantly
attenuated in TLR3/ cardiomyocytes as compared with WT
cells. This suggests that TLR3 mediates in part the necrotic
cell-induced cytokine production in mouse cardiomyocytes.
In an effort to identify endogenous ligands for TLR3 that may
mediate cardiac I/R injury, we explored the role of endogenous
exRNA in cardiac I/R injury. We administered RNase before,
during and after coronary occlusion. RNase has a small
molecular weight (17 kDa) and a short plasma half-life (only
min) with a rapid clearance primarily via kidney.54 The protocol
of RNase administration provided a markedly enhanced plasma
RNase activity for up to at least 4 hours. However, it remains
unclear how complete the digestion of exRNA would be by the
exogenously administered RNase in vivo as certain exosome-
associated RNA could be protected from RNase digestion20
and exRNA in the interstitial space might not be fully exposed
to circulating RNase. Nevertheless, using the RNase delivering
protocol, we demonstrated that mice treated with RNase had
signiﬁcantly reduced myocardial cytokine responses as well as
caspase-3 activation following I/R. Most importantly, RNase
administration also led to a signiﬁcant reduction in MI size
compared with normal saline treatment after I/R. Thus, we
identify circulating exRNA as a signiﬁcant contributor to
myocardial inﬂammation and injury following coronary occlu-
sion in the heart. These data are consistent with the theme that
exRNA is increasingly recognized as an important player in
diverse pathological conditions such as blood coagulation
following carotid artery injury28 and radiation-induced skin
damage.14 Of note, the fact that RNase administration and
TLR3 deﬁciency confer similar cardiac protection against I/R
injury (eg, reduced MI sizes and apoptosis) but differ in
myocardial inﬂammation (eg, neutrophil inﬁltration and cyto-
kine production) raises a possibility that exRNA and TLR3 may
contribute to I/R injury via different signaling pathways. The
possible role of TLR3 signaling in exRNA-mediated I/R injury
remains to be investigated.
In summary, the current study indicates that circulating
exRNA and TLR3-Trif signaling contribute to ischemic myo-
cardial injury. RNase treatment or loss of TLR3-Trif signaling
leads to reduced MI in a mouse model of I/R injury. Our data
suggest that TLR3-Trif signaling contributes to ischemic
myocardial injury most likely by mediating cardiac apoptosis
and plays no major role in myocardial inﬂammation during I/
R. Moreover, we propose that under ischemic condition,
cardiomyocytes in vitro and cardiac tissue in vivo release
RNA. Extracellular RNA in turn facilitates pro-inﬂammatory
cytokine responses in cardiomyocytes and contributes to
subsequent myocardial injury in the ischemic heart. Future
studies will be needed to delineate the signaling mechanisms
by which exRNA contributes to myocardial inﬂammation and
injury during I/R.
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